# AI-assisted Multi-domain Lifestyle Versus Tirzepatide for Weight Loss Maintenance in Adults With Type 2 Diabetes (AIM-MAINTAIN)

> **NCT07555730** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Huazhong University of Science and Technology** · enrollment: 400 (estimated)

## Conditions studied

- Overweight or Obesity; Type 2 Diabetes
- Weight Loss Maintenance

## Interventions

- **BEHAVIORAL:** AI assisted multi-domain lifestyle intervention
- **DRUG:** Tirzepatide

## Key facts

- **NCT ID:** NCT07555730
- **Lead sponsor:** Huazhong University of Science and Technology
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-30
- **Primary completion:** 2028-09-30
- **Final completion:** 2028-09-30
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2026-04-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07555730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07555730, "AI-assisted Multi-domain Lifestyle Versus Tirzepatide for Weight Loss Maintenance in Adults With Type 2 Diabetes (AIM-MAINTAIN)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07555730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*